Chemical Biology Research Center, School of Pharmaceutical Sciences , Wenzhou Medical University , Wenzhou , Zhejiang 325035 , China.
College of Chemistry and Materials Engineering , Wenzhou University , Wenzhou , Zhejiang 325035 , China.
ACS Chem Neurosci. 2019 Nov 20;10(11):4545-4557. doi: 10.1021/acschemneuro.9b00402. Epub 2019 Oct 22.
The supplementation of exogenous antioxidants to scavenge excessive reactive oxygen species (ROS) is an effective treatment for cerebral ischemia-reperfusion injury (CIRI) in stroke. Piperlongumine (PL), a natural alkaloid, has a great potential as a neuroprotective agent, but it also has obvious toxicity. Moreover, its neuroprotective effects remain to be improved. In this study, we designed a series of novel PL analogs by hybridizing the screened low-toxicity diketene skeleton with antioxidant effect and the 3,4,5-trimethoxyphenyl group, which may increase the antioxidant activity of PL. The intermediate was synthesized by a novel green synthesis method, and 34 compounds were obtained. The compounds without obvious cytotoxicity have remarkable antioxidant effects, especially compared with diketene skeletons and PL. The cytoprotection of the active compound decreased significantly by reduction of the carbon-carbon double bonds of the Michael acceptor in the diketene skeleton. More importantly, further study revealed that compound , which has the best activity, can confer protection for cells against oxidative stress and attenuate brain injury in vivo. Overall, this study provided a promising drug candidate for the treatment of CIRI and guided the further development of drug research in oxidative stress-mediated diseases.
补充外源性抗氧化剂以清除过多的活性氧(ROS)是治疗中风后脑缺血再灌注损伤(CIRI)的有效方法。胡椒碱(PL)是一种天然生物碱,具有很大的神经保护作用潜力,但也有明显的毒性。此外,其神经保护作用仍有待提高。在这项研究中,我们通过将筛选出的低毒性二烯酮骨架与抗氧化作用和 3,4,5-三甲氧基苯基基团杂交,设计了一系列新型 PL 类似物,这可能会增加 PL 的抗氧化活性。通过一种新型的绿色合成方法合成了中间体,并得到了 34 种化合物。无明显细胞毒性的化合物具有显著的抗氧化作用,特别是与二烯酮骨架和 PL 相比。二烯酮骨架中迈克尔受体的碳-碳双键还原后,活性化合物的细胞保护作用显著降低。更重要的是,进一步的研究表明,活性最好的化合物 ,可以保护细胞免受氧化应激,并减轻体内脑损伤。总的来说,这项研究为治疗 CIRI 提供了有前途的药物候选物,并指导了氧化应激介导疾病药物研究的进一步发展。